| Drug Name |
Apraclonidine hydrochloride |
| Drug ID |
BADD_D00155 |
| Description |
Apraclonidine, also known as iopidine, is a sympathomimetic used in glaucoma therapy. It is an alpha2-adrenergic agonist. |
| Indications and Usage |
For prevention or reduction of intraoperative and postoperative increases in intraocular pressure (IOP) before and after ocular laser surgery when used prophylactically. Also used as a short-term adjunctive therapy in patients with open-angle glaucoma who are on maximally tolerated medical therapy requiring additional IOP reduction. |
| Marketing Status |
approved |
| ATC Code |
S01EA03 |
| DrugBank ID |
DB00964
|
| KEGG ID |
D01008
|
| MeSH ID |
C016986
|
| PubChem ID |
51763
|
| TTD Drug ID |
D0MT0M
|
| NDC Product Code |
58567-103; 51014-7782; 17478-716 |
| UNII |
D2VW67N38H
|
| Synonyms |
apraclonidine | 4-aminoclonidine | para-aminoclonidine | 2-(4-amino-2,6-dichloro)phenyliminoimidazolidine | p-aminoclonidine | apraclonidine hydrochloride | Iopidine | Iopimax | ALO 2145 | ALO-2145 |
